Cranberry powder extract with high content of A-type Proanthocyanidins
KEY ACTIONS
RAW MATERIAL
CHARACTERISTIC MOLECULES
ACTION
PACs present in cranberry can promote the maintenance of a healthy urinary tract; in particular, A-type PACs counteract the adhesion of uropathogenic bacteria to the bladder epithelium.
This interaction inhibits the initial stage of infection, resulting in a beneficial preventive action in the lower urinary tract and combating the onset of common urinary tract disorders (e.g. cystitis).
The consumption of these fruits favors important physiological effects such as the drainage of body fluids, the functionality of the urinary tract, an antioxidant action and the regularity of intestinal transit.
RAW MATERIALS
Cranberry
Vaccinium macrocarpon Aiton is a shrub belonging to the Ericaceae family, native to North America.
The plant produces large red fruits, which are traditionally eaten as foodstuffs and mainly used to make juices with well-known disinfectantand anti-inflammatory properties.
FORMULATIONS
Oximacro® is available in:
- Powder, titrated at 36% w/w total PACs, of which 85% are A-type PACs
- Powder, titrated at 22% w/w total PACs, of which 80% are A-type PACs (NEW)
- Powder, titrated at 15% w/w total PACs, of which 80% are A-type PACs (NEW)
Oximacro® is first titrated using the BL-DMAC method to obtain the number of total PACs and then analysed by liquid chromatography coupled to mass spectrometry (HPLC-ESI-MS/MS) to assess the content of A-type PACs
INSIGHTS
INSIGHTS ABOUT OXIMACRO®
